An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

Status:
Completed

Trial end date:
2017-06-22

Target enrollment:

Participant gender:

The objective of this Phase 2 trial is to determine the efficacy and safety of LYC-30937-EC in patients with moderate plaque-type psoriasis.

Phase 2

Lycera Corp.